C. Greg Guyer

2020

In 2020, C. Greg Guyer earned a total compensation of $6.3M as Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations at BioMarin Pharmaceutical.

Compensation breakdown

Bonus$250,000
Non-Equity Incentive Plan$262,500
Option Awards$2,109,894
Salary$392,308
Stock Awards$3,166,214
Other$162,583
Total$6,343,499

Guyer received $3.2M in stock awards, accounting for 50% of the total pay in 2020.

Guyer also received $250K in bonus, $262.5K in non-equity incentive plan, $2.1M in option awards, $392.3K in salary and $162.6K in other compensation.

Rankings

In 2020, C. Greg Guyer's compensation ranked 1,617th out of 13,090 executives tracked by ExecPay. In other words, Guyer earned more than 87.6% of executives.

ClassificationRankingPercentile
All
1,617
out of 13,090
88th
Division
Manufacturing
609
out of 5,620
89th
Major group
Chemicals And Allied Products
218
out of 2,253
90th
Industry group
Drugs
182
out of 1,953
91st
Industry
Pharmaceutical Preparations
127
out of 1,458
91st

Pay ratio

C. Greg Guyer's Pay$6,343,499
Median Employee's Pay$181,141
Pay Ratio

35

to 1

In 2020, the annual total compensation of C. Greg Guyer was $6,343,499.

The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.

The ratio of C. Greg Guyer's pay to the pay of median employee was therefore 35 to one.

Source: SEC filing on April 13, 2021.

Guyer's colleagues

We found six more compensation records of executives who worked with C. Greg Guyer at BioMarin Pharmaceutical in 2020.

2020

Jean-Jacques Bienaim

BioMarin Pharmaceutical

Chief Executive Officer

2020

Henry Fuchs

BioMarin Pharmaceutical

President, Worldwide R&D

2020

Brian Mueller

BioMarin Pharmaceutical

Chief Financial Officer

2020

Robert Baffi

BioMarin Pharmaceutical

Former President of Global Manufacturing and Technical Operations

2020

Jeff Ajer

BioMarin Pharmaceutical

Executive Vice President, Chief Commercial Officer

2020

Daniel Spiegelman

BioMarin Pharmaceutical

Chief Financial Officer

News

You may also like